Sanofi

News

Sanofi Appoints Dr. Gary J. Nabel as Chairman of the Strategic Development and Scientific Advisory Council

News

Top-Selling Drugs for Ultra-Rare Diseases

News

Entering the Age of the $1 Million Medicine

News

US FDA New Drug Approvals Hit 16-Year High in 2012

News

Number of New Drugs Picks Up in Europe and U.S.

News

EU Agency Rejects Sanofi, Isis Cholesterol Drug

News

More Pressure to Justify Cost of Cancer Drugs Versus Benefits

News

Bayer Diabetes Unit Sale Unlikely

News

Drug Industry Treading Water on R&D Productivity

News

Human Stool Treatment Upends Race to Treat Colon Germ

News

GSK and J&J Lead Rivals in Drug Access for Poor

News

German Research Points Way to Faster Flu Vaccines

Topics • Technology

Sanofi Lets Genzyme's Biotech Culture Call the Shots

News

Sanofi Draws Fire Over Cost of MS Drug Lemtrada

News

Strong Refining Margins Boost Total Q3

News

Sanofi Sees Relief from Patent Loss Pain

News

FDA Reviewers Spot Safety Concerns With Sanofi, Isis Lipid Drug

136 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

INOSIM GmbH

Predictive Simulation in Pharma Production

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.